What Is Escitalopram (Lexapro)? Uses, Side Effects & Warnings

Escitalopram, sold as Lexapro (and widely available as generic), is a selective serotonin reuptake inhibitor (SSRI) that is consistently ranked among the most well-tolerated and commonly prescribed antidepressants in the United States. It is chemically derived from citalopram (Celexa) — it is the purified active component of that drug — and is considered by many clinicians to have the most favorable drug interaction profile and one of the highest efficacy-to-tolerability ratios among SSRIs. Escitalopram is available in 5 mg, 10 mg, and 20 mg tablets, as well as a liquid oral solution.

What Escitalopram Is Used For

Escitalopram has two FDA-approved indications. It treats major depressive disorder (MDD) in adults and adolescents aged 12 and older. It also treats generalized anxiety disorder (GAD) in adults. These two indications reflect clinical trials where escitalopram demonstrated clear, consistent efficacy in both conditions — notable because GAD and MDD, while frequently co-occurring, represent distinct diagnostic categories.

Off-label, escitalopram is used for panic disorder, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder (PMDD). Its broad serotonergic activity across anxiety and mood circuits makes it clinically effective for this range of conditions even where formal FDA approval is absent. It is often chosen when a physician wants an SSRI with the least potential for drug interactions, such as in patients taking multiple medications for other conditions.

How Escitalopram Works

Escitalopram works by blocking the serotonin transporter (SERT), preventing the reuptake of serotonin from the synapse back into the presynaptic neuron. This increases the amount of serotonin available to bind to postsynaptic receptors, gradually altering the neurotransmitter signaling involved in mood regulation, anxiety, sleep, and appetite. The "selective" in SSRI means it acts primarily on the serotonin system with minimal effects on norepinephrine, dopamine, or other receptors — which is why SSRIs generally have fewer side effects than older antidepressants.

Escitalopram is distinguished from other SSRIs by its particularly high selectivity for SERT. It has minimal off-target binding to histamine, muscarinic, or adrenergic receptors — receptor systems whose blockade is responsible for many of the side effects of older antidepressants (sedation, dry mouth, weight gain, urinary retention). Additionally, escitalopram minimally inhibits the cytochrome P450 enzyme system, which means it is less likely to interfere with the metabolism of other medications. This makes it a preferred SSRI in patients with complex medication regimens.

Common Side Effects

• Sexual dysfunction — reduced libido, difficulty with orgasm, delayed ejaculation; common to all SSRIs
• Nausea — common early in treatment, usually improves within 1–2 weeks
• Insomnia or sleep disturbances
• Drowsiness or fatigue in some patients
• Dry mouth
• Sweating
• Headache
• Diarrhea
• Weight gain — modest, more likely with long-term use

Important Warnings

The QT prolongation warning is a meaningful distinction from sertraline and fluoxetine. While all SSRIs carry some cardiac caution, escitalopram's dose-related QT effect is specifically called out in prescribing information and influenced the FDA to issue guidance limiting the maximum recommended daily dose.

Serotonin syndrome risk exists when escitalopram is combined with MAOIs, other serotonergic drugs, triptans, tramadol, or St. John's Wort. A 14-day washout period is required before and after MAOI use.

Discontinuation Syndrome

Abruptly stopping escitalopram can trigger discontinuation syndrome — dizziness, nausea, irritability, insomnia, flu-like symptoms, and the characteristic "brain zaps." Escitalopram has an intermediate half-life (about 27–32 hours), which puts it in the middle of the spectrum: more discontinuation symptoms than fluoxetine (very long half-life), fewer than paroxetine (very short half-life). Tapering the dose gradually over weeks to months minimizes these symptoms.

Key Drug Interactions

MAOIs are absolutely contraindicated — combining escitalopram with an MAOI can cause fatal serotonin syndrome. Other QT-prolonging drugs (antipsychotics, certain antibiotics, antiarrhythmics, methadone) should be avoided or used only with ECG monitoring. Escitalopram weakly inhibits CYP2D6, which can raise levels of certain drugs metabolized by this enzyme. NSAIDs increase bleeding risk when combined with SSRIs. Alcohol potentiates CNS depression.

Frequently Asked Questions

How is escitalopram different from citalopram?

Citalopram is a racemic mixture of two mirror-image molecules (the R and S enantiomers). Escitalopram is the purified S-enantiomer — the active half. By removing the inactive R-enantiomer, escitalopram achieves equivalent antidepressant effect with less drug, fewer metabolic byproducts, fewer drug interactions, and at approved doses, a modestly better cardiovascular profile compared to high-dose citalopram.

What is QT prolongation and why does it matter?

The QT interval on an ECG measures how long the heart takes to electrically reset between beats. When prolonged, the heart is at risk of a dangerous rhythm disturbance called torsades de pointes, which can cause sudden cardiac arrest. Escitalopram causes dose-dependent QT prolongation, a property that distinguishes it from most other SSRIs. It should not be used in patients with pre-existing QT prolongation or in combination with other QT-prolonging drugs without cardiac monitoring.

Is escitalopram good for anxiety as well as depression?

Yes — escitalopram is one of the few antidepressants with FDA approval specifically for both major depressive disorder and generalized anxiety disorder. This dual indication in distinct conditions reflects strong clinical trial evidence in both. It is also commonly used off-label for other anxiety disorders, often favored because of its tolerability and low drug interaction potential.